摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(E)-2-Cyano-N-{4-[(E)-2-cyano-3-(4-hydroxy-3-methoxy-5-nitro-phenyl)-acryloylamino]-butyl}-3-(4-hydroxy-3-methoxy-5-nitro-phenyl)-acrylamide

中文名称
——
中文别名
——
英文名称
(E)-2-Cyano-N-{4-[(E)-2-cyano-3-(4-hydroxy-3-methoxy-5-nitro-phenyl)-acryloylamino]-butyl}-3-(4-hydroxy-3-methoxy-5-nitro-phenyl)-acrylamide
英文别名
Dimeric Tyrphostin 11;(E)-2-cyano-N-[4-[[(E)-2-cyano-3-(4-hydroxy-3-methoxy-5-nitrophenyl)prop-2-enoyl]amino]butyl]-3-(4-hydroxy-3-methoxy-5-nitrophenyl)prop-2-enamide
(E)-2-Cyano-N-{4-[(E)-2-cyano-3-(4-hydroxy-3-methoxy-5-nitro-phenyl)-acryloylamino]-butyl}-3-(4-hydroxy-3-methoxy-5-nitro-phenyl)-acrylamide化学式
CAS
——
化学式
C26H24N6O10
mdl
——
分子量
580.511
InChiKey
KELGROZXKWYKRA-ZEELXFFVSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    42
  • 可旋转键数:
    11
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.23
  • 拓扑面积:
    256
  • 氢给体数:
    4
  • 氢受体数:
    12

反应信息

  • 作为产物:
    描述:
    5-硝基香兰素2-cyano-N-[4-(2-cyanoacetylamino)butyl]acetamide哌啶 作用下, 以 乙醇 为溶剂, 反应 2.0h, 以58%的产率得到(E)-2-Cyano-N-{4-[(E)-2-cyano-3-(4-hydroxy-3-methoxy-5-nitro-phenyl)-acryloylamino]-butyl}-3-(4-hydroxy-3-methoxy-5-nitro-phenyl)-acrylamide
    参考文献:
    名称:
    Tyrphostins. 6. Dimeric Benzylidenemalononitrile Tyrphostins:  Potent Inhibitors of EGF Receptor Tyrosine Kinase in Vitro
    摘要:
    Benzylidenemalononitrile (BMN) tyrphostins were previously found to be potent inhibitors of EGF receptor (EGFR) tyrosine kinase activity. Since these compounds were found to compete for the substrate and sometimes with the ATP site and since EGFR acts as a dimer, we prepared a series of dimeric tyrphostins. These dimeric tyrphostins were built from two BMN units linked by various spacers and designed to fit the dimeric cross-autophosphorylation signal transduction intermediate of the EGFR tyrosine kinases. Structure-activity relationship of these potent dimeric EGF receptor tyrosine kinase inhibitors is reported.
    DOI:
    10.1021/jm960225d
点击查看最新优质反应信息